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The management of idiopathic ventricular ﬁbrillation is
challenging. While the exact underlying mechanism remains
elusive, the Purkinje system appears to be critically involved
in many cases. Medical therapy is largely empirical and
ablation may be required in patients with drug-refractory
arrhythmia. However, targets for ablation may be difﬁcult to
identify when the spontaneous arrhythmia occurs infre-
quently. In this setting, 12-lead Holter monitoring is
extremely useful in identifying a potential target for mapping
and ablation prior to the electrophysiology study.Case report
A 40-year-old woman presented with recurrent syncope
without warning that occurred at rest. Her medical history
and family history were unremarkable. Resting 12-lead ECG
showed sinus rhythm with an RsR0 in lead V2, normal QT
interval, and, speciﬁcally, no suggestion of Brugada pattern
or arrhythmogenic right ventricular cardiomyopathy
(Figure 1). Early repolarization was not observed at any
point. Echocardiography and cardiac magnetic resonance
imaging were normal. Exercise testing and ﬂecainide chal-
lenge were unremarkable.
During admission to the hospital, 2 short episodes of
nonsustained ventricular tachycardia (VT) were recorded
(Figure 2). The coupling interval of the initiating premature
ventricular complex (PVC) was approximately 280–300 ms,
and the overall burden of PVCs was low (o10 in 24 hours).
Electrophysiologic study (EPS) was performed. Baseline
intervals were normal, as were anterograde and retrograde
conduction. Spontaneous PVCs were not observed. Atrial
and ventricular burst pacing were performed and repeatedKEYWORDS Ventricular ﬁbrillation; Purkinje; Ablation; Sudden death; Holter
ABBREVIATIONS EPS ¼ electrophysiologic study; ICD ¼ implantable
cardiac defibrillator; LV ¼ left ventricle; PVC ¼ premature ventricular
complex; VF ¼ ventricular fibrillation; VT ¼ ventricular tachycardia
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arrhythmia induction. Up to 4 ventricular extrastimuli from
the right ventricular apex to 10 ms above the refractory
period failed to induce arrhythmia.
With a presumptive diagnosis of idiopathic polymorphic
VT, a deﬁbrillator was implanted, and quinidine therapy was
commenced (10 mg/kg/d). The decision to implant a
deﬁbrillator was extremely challenging and was reached
only after extensive consultation with electrophysiology
colleagues and in-depth discussions with the patient and
her family. The presence of recurrent syncope, the relative
short coupling interval of the initiating PVC, and the short
cycle length of the polymorphic VT inﬂuenced the decision.
Three months later, the patient presented after another
episode of syncope. Interrogation of her implantable cardiac
deﬁbrillator (ICD) revealed sustained polymorphic VT degen-
erating into ventricular ﬁbrillation (VF), which was treated
successfully with a shock (Figure 3A). Several other episodes
of nonsustained polymorphic VT also were observed.
The patient had been compliant with quinidine therapy,
and atenolol 25 mg twice daily was added. Four weeks later,
she complained of lightheadedness while she was taking her
children to school. Interrogation of the device showed some
reduction in resting heart rate after initiation of beta-blocker
treatment but more frequent episodes of VT (Figure 3B).
Twelve-lead Holter monitoring (SEER 12-channel Holter
ECG Digital Recorder; GE Medical Systems, Milwaukee,
WI) was performed with the limb lead electrodes placed in a
Mason-Likar conﬁguration on the torso and the precordial
leads in a standard position. Holter monitoring revealed
several episodes of nonsustained polymorphic VT initiated
by stereotypical PVC with a narrow QRS, qR pattern in lead
V1, and left superior axis (Figure 4C).
The patient was admitted to the hospital. Quinidine and
atenolol were discontinued, and EPS was repeated 5
days later.
Multipolar recording catheters were placed in the coro-
nary sinus, His-bundle position, and right ventricle. Care was
taken to position the surface ECG electrodes in the same
position as the Holter monitor. Using a retroaortic approach,
a decapolar catheter and roving ablation catheter were placed
against the left ventricular septum to map Purkinje potentialspen access article under the CC BY-NC-SA license
http://dx.doi.org/10.1016/j.hrcr.2015.02.008
Figure 2 Telemetry recordings demonstrating nonsustained episodes of
polymorphic ventricular tachycardia. Both episodes are initiated by a short
coupled (280–300 ms) premature ventricular beat.
KEY TEACHING POINTS
 Twelve-lead Holter monitoring may allow
identiﬁcation of a potential target for ablation in
cases of idiopathic ventricular ﬁbrillation (VF),
especially in patients with a low arrhythmia
burden.
 Purkinje-related arrhythmias can manifest as both
monomorphic and polymorphic ventricular
tachyarrhythmias in patients with normal hearts as
well as in patients with structural heart disease or
channelopathy.
 Purkinje-related polymorphic ventricular
tachycardia and VF may not respond to beta-
blockade or ﬂecainide therapy but may be
amenable to catheter ablation.
Heart Rhythm Case Reports, Vol 1, No 5, September 2015270suggested by the morphology of the initiating PVC on Holter
monitoring. The catheter positions in the left anterior oblique
view are shown in Figure 5. The intracardiac electrograms in
sinus rhythm are shown in Figure 6A. Presystolic Purkinje
potentials were recorded during sinus rhythm with proximal-
to-distal activation on the septally placed left ventricular
(LV) catheters (indicated by the arrow; activation from
proximal to distal LV catheter).
PVCs were not observed in the baseline state or during
isoprenaline infusion. After right ventricular burst pacing,
nonsustained polymorphic VT was observed on 2 occasions
over a 60-minute period. The morphology of the initiating
PVC was very similar to the PVC previously documented on
Holter monitoring (Figure 4).
Intracardiac electrograms recorded during an episode of
polymorphic VT are shown in Figure 6. Purkinje potentials
preceded the initiating PVC as well as both diastolic and
presystolic Purkinje potentials during tachycardia, with
variation in the duration from Purkinje potential to
QRS onset. On beats 1 and 4, there also appeared to be aFigure 1 Baseline 12-leaproximal-to-distal activation sequence of the presystolic
potentials.
Radiofrequency ablation (irrigated, 35 W) was performed
in the mid-LV septum at the site of earliest presystolic
Purkinje potential during the initiating PVC. During abla-
tion, there were ventricular ectopic beats, presumably related
to automaticity from the Purkinje system. There was
apparent loss of local Purkinje potentials at the ablation site,
but the delay in the occurrence of the local ventricular
electrogram was minimal (o10 ms). Diastolic potentials
were not observed during sinus rhythm at the ablation
site. Ablation was empirically extended in a linear fashion
over 2–3cm, perpendicular to the long axis of the leftd electrocardiogram.
Figure 3 A: Printout of the implantable cardiac deﬁbrillator (ICD) during syncope. Ventricular ﬁbrillation is detected and successfully treated with a shock.
B: Incidence of VF/VT episodes detected and treated by the ICD under medical treatment and after ablation. AEGM¼ atrial electrocardiogram; MAR¼marker
channel; NSVT¼ nonsustained ventricular tachycardia; VEGM¼ right ventricular tip-to-ring electrocardiogram; VF¼ ventricular ﬁbrillation; VT¼ ventricular
tachycardia.
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of interest. Care was taken to avoid more proximal
ablation near the His bundle or bifurcation of the left
anterior and posterior fascicles. No spontaneous PVCs
were observed after ablation, and tachycardia was non-
inducible. Mitral valve function was unaffected by
ablation. The patient has been arrhythmia-free for 9
months without medical therapy.
Discussion
Clinical characteristics
We describe a case of idiopathic polymorphic VT likely
related to reentry in the left posterior fascicular network. The
clinical characteristics of the arrhythmia were as follows.
Arrhythmia occurred in a middle-aged subject in the absence
of demonstrable structural heart disease or channelopathy.
Polymorphic VT occurred at rest and was unresponsive to
empirical quinidine and beta-blocker therapy, the latter
possibly associated with an increased frequency of arrhyth-
mia. Spontaneous arrhythmia occurred very infrequently,
was not provokable by adrenergic stimulation, and wasinconsistently induced with pacing. The case was challeng-
ing because of the paucity of clinical arrhythmia. It high-
lights the use of 12-lead Holter monitoring during periods of
increased symptoms.1 The observation of initiating mono-
morphic short-coupled PVCs was critical in identifying the
left posterior fascicular network as the likely culprit. This
allowed targeted mapping of the arrhythmia during the
repeat EPS.Mechanistic considerations
Gelatinous ﬁbers in the ventricular subendocardium were
ﬁrst described by Purkinje2 in 1885. The function of the
Purkinje ﬁbers as part of the conduction system was
subsequently assessed by Tawara3 in 1905. Polymorphic
VT was reported by Zipes et al4 in 1979. Belhassen et al5
found that verapamil was effective in suppressing ventricular
arrhythmias related to the Purkinje system. The presence of
Purkinje ﬁber potentials and successful ablation at the site of
these potentials in this patient group were described in 1993
by Nakagawa et al.6
Figure 4 Polymorphic ventricular tachycardia (PMVT) preceded by a
short coupled premature ventricular beat with a narrow QRS complex, qR
pattern in lead V1, and left superior axis. Morphology is nearly identical in
the initiating beat recorded on Holter monitoring (A) and during electro-
physiologic study (EPS) (B).
Figure 5 Left anterior oblique (LAO) projection of catheter positions
during mapping of Purkinje potentials. The mapping catheter and decapolar
catheter are positioned using a retroaortic approach on the left septum. The
dual-chamber implanted deﬁbrillator and leads are visible. CS ¼ coronary
sinus; HBE¼ His-bundle electrode; LV¼ left ventricle; RA¼ right atrium;
RV ¼ right ventricle.
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monomorphic or polymorphic (Table 1). The mechanism of
monomorphic VT is eclectic but generally believed to be due
to either reentry using the fascicles and/or bundle branches
and/or myocardium, or possibly focal automaticity of
Purkinje tissue. These are potentially treatable by ablation.
VF is of unknown mechanism but is thought to be
perpetuated by reentry or spiral waves throughout the
myocardium. Purkinje ﬁber involvement in VF initiation
has been demonstrated in Brugada syndrome, long QT
syndrome, amyloidosis, chronic myocarditis, cardiomyopa-
thies, and catecholaminergic polymorphic VT. Leenhardt
et al7 described the involvement of the Purkinje system in VF
initiated by short-coupled premature beats in normal hearts.
Why these triggers cause VF in some individuals and not
others is unclear. Other potential “triggers” of idiopathic VF
have been described in the right and left ventricular outﬂow
tracts, pulmonary artery, and papillary muscle.1,8,9
It has been postulated that the mechanism of the short-
coupled variant of Purkinje-related polymorphic VT/VF
depends on calcium overload in the Purkinje tissue and
defective “gating” in the Purkinje system. Calcium overload
in Purkinje tissue results in delayed potentials, leading to
reentry in the Purkinje network due to defective gate
function.10 Abnormal dispersion in the refractory period of
the Purkinje network allows signals from the myocardium to
reenter the system and result in a reentrant tachycardia.11
Ablation of the culprit Purkinje ﬁbers as a treatment
strategy was described in 2002 by Haissaguerre et al,12,13who targeted the earliest Purkinje signals relative to the QRS
during the premature beats. A short (o10-ms duration) sharp
potential preceding a larger ventricular electrogram during
sinus rhythm and ectopic beats (by 11 and 36 ms, respec-
tively) suggested a Purkinje signal, whereas the absence of
such a signal at the site of earliest activation suggested an
origin from ventricular muscle.13 Bänsch et al14 described
suppression of VF in patients after myocardial infarction by
ablation of Purkinje signals preceding premature ventricular
beats. They observed Purkinje potentials preceding ventric-
ular activation in sinus rhythm by 23–26 ms and preceding
the premature beats by 126–160 ms. Targeting ablation to
these signals resulted in suppression of VF.
Absence of spontaneous PVCs and noninducibility of VT
are clinical end-points of ablation, but these are not always
practical as demonstrated in the present case. Surrogate end-
points include the abolition of local Purkinje potentials and a
slight delay in the occurrence of the local ventricular
electrogram at the site of ablation during sinus rhythm.13
The demonstration of diastolic Purkinje potentials indicating
intra-Purkinje conduction block is another potential end-
point.15,16 Moreover, it is unknown whether clinical success
may be enhanced by additional “substrate modiﬁcation”
within the neighboring Purkinje network to address multiple
foci or local reentry.1 However, more extensive ablation may
increase the possibility of collateral injury to the conduction
system (especially with more proximal ablation) as well as
injury to the mitral valve apparatus.
Clinical observations suggest that the mechanism of
Purkinje system–initiated VF can display characteristics of
both triggered activity and reentry.17 Rapid polymorphic
VTs may be induced by a ventricular premature beat with
short coupling intervals as well as atrial burst pacing.
Arrhythmias may be suppressed by verapamil, suggesting
Figure 6 Intracardiac electrocardiograms. A: Arrow highlights the proximal-to-distal activation of presystolic Purkinje potentials along the septum in sinus
rhythm. B: Episode of polymorphic ventricular tachycardia. Black arrows indicate presystolic Purkinje potentials. White arrows indicate diastolic Purkinje
potentials. S9,10 were located at the proximal left ventricular septum. MAP indicates signals from the ablation catheter, which was positioned parallel to the
decapolar catheter.
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the observation that VF suppression may occur after ablation
from within the Purkinje system but not at the site with the
earliest ventricular signal may suggest a reentrant circuit
involving the Purkinje system.1
Quinidine has been found to be effective in suppressing
VF in patients with Brugada syndrome and idiopathic VF.18
However, the patient in the current report continued to
experience arrhythmias despite empirical quinidine therapy.
Verapamil has also been used to suppress idiopathic ven-
tricular tachyarrhythmia.5,7 However, neither medicalTable 1 Categories of Purkinje system arrhythmias
Monomorphic VT Polymorphic VT/VF
I. Verapamil-sensitive left
fascicular VT
I. Idiopathic VF
II. Purkinje ﬁber–mediated
VT postinfarct
II. VF in ischemic heart disease
III. Bundle branch/
interfascicular reentrant VT
III. Associated with structural
heart disease
A. Myocarditis
B. Amyloidosis
C. Nonischemic cardiomyopathy
D. Aortic valve disease
IV. Focal Purkinje VT IV. Associated with channelopathy
(long QT syndrome, Brugada
syndrome)
VF ¼ ventricular ﬁbrillation; VT ¼ ventricular tachycardia.
Adapted from Nogami.15therapy nor catheter ablation provides absolute protection
from sudden death.7,19 For example, Knecht et al19 reported
a recurrence rate of 18% in 38 patients who underwent
apparently successful ablation for idiopathic VF. This
ﬁnding would argue for ICD placement in these individuals
regardless of the apparent success of ablation and/or medical
therapy.
Practical considerations
Practical lessons from the present case include the need for
repeated evaluation at times of increased arrhythmia burden
because of the stochastic nature of this speciﬁc arrhythmia.
Twelve-lead Holter monitoring may be extremely useful in
identifying a potential target for mapping and ablation before
the electrophysiologic procedure. Management may involve
a combination of medical therapy (probably with verapamil),
ablation where feasible, and ICD implantation.
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